Company intelligence / Profile preview
FunPep
Tokyo, Tokyo Prefecture, Japanfunpep.co.jp ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
FunPep has developed a proprietary platform for creating functional and antibody-inducing peptides. Its lead program, FPP003, completed a PI/IIa trial showing it was generally well tolerated with no serious adverse events and demonstrated immunological response in humans. The company claims to be the first to produce sustained antibodies via administration of a peptide alone, confirming the concept of antibody-inducing peptides in clinical trials[5].
- Therapeutic areas
- OncologyImmunologyCardiovascularNeurologyInfectious Diseases
- Modalities
- PeptidesAntibody-inducing peptidesFunctional peptidesPeptide-based medicines[1][3][5]
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Shionogi & Co., Ltd. – Lead asset licensed for allergy vaccine development [1][3]Sumitomo Pharma – Optioned clinical asset [3]MEDIPAL HOLDINGS CORPORATION – Exercised option agreement [1]
Beyond the preview
Go deeper on FunPep.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FunPep.